FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/11/021957 [Registered on: 11/11/2019] Trial Registered Prospectively
Last Modified On: 10/11/2019
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   DESCRIPTIVE 
Study Design  Other 
Public Title of Study   INTRATUMOR HORMONE RECEPTOR HETEROGENEITY IN BREAST CANCER. 
Scientific Title of Study   ASSESSMENT OF HORMONE RECEPTOR EXPRESSION HETEROGENEITY IN CARCINOMA BREAST:AN IMMUNOHISTOCHEMICAL STUDY 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  PRIYANKA YADAV 
Designation  PG RESIDENT 
Affiliation  MAULANA AZAD MEDICAL COLLEGE 
Address  DEPARTMENT OF PATHOLOGY MAULANA AZAD MEDICAL COLLEGE NEW DELHI

Central
DELHI
110002
India 
Phone  8527626343  
Fax    
Email  priyankayadavnb@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  NITA KHURANA 
Designation  PROFESSOR AND HEAD OF DEPARTMENT 
Affiliation  MAULANA AZAD MEDICAL COLLEGE NEW DELHI 
Address  DEPARTMENT OF PATHOLOGY MAULANA AZAD MEDICAL COLLEGE NEW DELHI

Central
DELHI
110002
India 
Phone  9968604289  
Fax    
Email  nitakhurana@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  PRIYANKA YADAV 
Designation  PG RESIDENT 
Affiliation  MAULANA AZAD MEDICAL COLLEGE 
Address  DEPARTMENT OF PATHOLOGY MAULANA AZAD MEDICAL COLLEGE NEW DELHI

Central
DELHI
110002
India 
Phone  8527626343  
Fax    
Email  priyankayadavnb@gmail.com  
 
Source of Monetary or Material Support  
MAULANA AZAD MEDICAL COLLEGE NEW DELHI 
 
Primary Sponsor  
Name  PRIYANKA YADAV 
Address  DEPARTMENT OF PATHOLOGY MAULANA AZAD MEDICAL COLLEGE NEW DELHI 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
PRIYANKA YADAV  MAULANA AZAD MEDICAL COLLEGE NEW DELHI  ROOM NO 62 DEPARTMENT OF PATHOLOGY MAULANA AZAD MEDICAL COLLEGE NEW DELHI
Central
DELHI 
8527626343

priyankayadavnb@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C50||Malignant neoplasm of breast,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Female 
Details  1 Newly diagnosed cases of breast carcinoma.
2 Age more than 18 year.
3 Willing to get treated in the same hospital
 
 
ExclusionCriteria 
Details  1 Previous endocrine or chemotherapy
2 Patients undergone lumpectomy as diagnostic procedure
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
IMMUNOHISTOCHEMICAL VARIATION IN ER PR HER2NEU   6 MONTHS  
 
Secondary Outcome  
Outcome  TimePoints 
ASSOCIATION OF HORMONE RECEPTOR EXPRESSION WITH REPONSE TO CHEMOTERAPY  6 MONTHS 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/11/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   THIS STUDY IS AN OBSERVATIONAL IMMUNIHISTOCHEMICAL STUDY WHICH AIMS AT STUDYING THE VARIANCE IN ER PR HER2NEU EXPRESSION IN SAMPLE OBTAINED VIA TRUCUT BIOPSY AND THEIR COMPLETE EXCISION SPECIMEN AND ALSO THE VARIANCE OCCURING DUE TO CHEMOTHERAPY. 
Close